Cart
sales@molnova.com
RS 25344 hydrochloride
CAS No. 152815-28-6
RS 25344 hydrochloride ( —— )
Catalog No. M23660 CAS No. 152815-28-6
RS 25344 hydrochloride is a phosphodiesterase (PDE) 4 inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 72 | In Stock |
|
| 10MG | 115 | In Stock |
|
| 25MG | 260 | In Stock |
|
| 50MG | 410 | In Stock |
|
| 100MG | 605 | In Stock |
|
| 500MG | 1287 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRS 25344 hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionRS 25344 hydrochloride is a phosphodiesterase (PDE) 4 inhibitor.
-
DescriptionRS 25344 hydrochloride is a phosphodiesterase (PDE) 4 inhibitor
-
Synonyms——
-
PathwayAngiogenesis
-
TargetPDE
-
Recptorphosphodiesterase (PDE) 4
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number152815-28-6
-
Formula Weight411.8
-
Molecular FormulaC19H14ClN5O4
-
Purity>98% (HPLC)
-
SolubilityDMSO:80mg/ml(194.27mM; need ultrasonic)
-
SMILESO=C1N(C2=CC=CC([N+]([O-])=O)=C2)C3=NC=CC=C3C(N1CC4=CC=NC=C4)=O.[H]Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Drotaverine hydrochl...
Drotaverine hydrochloride is a type 4 cyclic nucleotide phosphodiesterase (PDE4) inhibitor,and is an antispasmodic drug, used to enhance cervical dilation during childbirth.?
-
Mirodenafil
Mirodenafil is a PDE-5 inhibitor developed for the treatment of erectile dysfunction.The pharmacoki-netics of mirodenafil were not significantly altered by this concurrent administration. Mirodenafil (50 or 100 mg), obviously improved erectile function and was well tolerated in a representative population of Korean men with broad-spectrum ED of various etiologies and severities.
-
Olprinone
Olprinone(Loprinone) is a selective phosphodiesterase 3 (PDE3) inhibitor.Olprinone has been reported to improve microcirculation and attenuate inflammation. Olprinone is often used to increase cardiac output after cardiopulmonary bypass (CPB).
